Nuvalent (NUVL) Times Interest Earned (2020 - 2026)

Nuvalent (NUVL) posted Times Interest Earned of -$0.26 for Q1 2026, down 19.53% on a QoQ basis from -$0.21 in Q4 2025, and up 9.57% year-over-year from -$0.23 in Q1 2025.

Nuvalent (NUVL) Times Interest Earned (2020 - 2026) Analysis & Trends

Nuvalent's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.26 for Q1 2026.

  • Quarterly Times Interest Earned rose 9.57% year-over-year to -$0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.94 (up 2.31% YoY) and the FY2025 annual result came in at -$0.87, down 23.59% from the prior year.
  • Times Interest Earned was -$0.26 for Q1 2026 at Nuvalent, down from -$0.21 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$0.1 in Q4 2023 and bottomed at -$59.0 in Q1 2023.
  • A 5-year average of -$13.51 and a median of -$0.29 in 2025 frame the typical range for Times Interest Earned.
  • Annual changes were most pronounced in 2022 — Times Interest Earned tumbled 2833.23% — and 2024, when it surged 99.58%.
  • Nuvalent's Times Interest Earned stood at -$21.78 in 2022, then surged by 99.53% to -$0.1 in 2023, then slumped by 109.63% to -$0.22 in 2024, then rose by 0.93% to -$0.21 in 2025, then retreated by 19.53% to -$0.26 in 2026.
  • Business Quant data shows NUVL's Times Interest Earned at -$0.26 in Q1 2026, -$0.21 in Q4 2025, and -$0.26 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Nuvalent 9.75 Bn 9.75 Bn - -0.26

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.26
Dec 31, 2025 -0.21
Sep 30, 2025 -0.26
Jun 30, 2025 -0.29
Mar 31, 2025 -0.28
Dec 31, 2024 -0.22
Sep 30, 2024 -0.12
Jun 30, 2024 -0.15
Mar 31, 2024 -37.91
Dec 31, 2023 -0.10
Sep 30, 2023 -29.61
Jun 30, 2023 -22.16
Mar 31, 2023 -59.00
Dec 31, 2022 -21.78
Sep 30, 2022 -23.52
Jun 30, 2022 -16.53
Mar 31, 2022 -17.31
Dec 31, 2021 -0.74
Dec 31, 2020 -0.53